Cagrilintide (10 mg Vial)

Cagrilintide (10 mg Vial) is supplied as a lyophilized vial for laboratory research use. This page covers reconstitution volume, the resulting concentration, U-100 syringe equivalents and storage handling.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Cagrilintide (10 mg Vial)

Synonyms/Alias: Cagrilintide

Purity: Specification by inquiry

Custom Peptide Support

  • Sequence, purity and scale confirmation
  • CoA and technical documentation requests
  • API, research and cosmetic peptide options
  • Distributor and institution quotation support

Cagrilintide (10 mg Vial) is supplied as a lyophilized vial for laboratory research use. This page covers reconstitution volume, the resulting concentration, U-100 syringe equivalents and storage handling.

Quickstart

Reconstitute: Add 3.0 mL bacteriostatic water β†’ ~ 3.33 mg/mL concentration.

Typical weekly range: 0.6–4.5 mg once weekly (gradual titration over 4–6 weeks).

Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL β‰ˆ 0.0333 mg (33.3 mcg) on a U‑100 insulin syringe.

Storage: Lyophilized: store frozen at βˆ’20 Β°C (βˆ’4 Β°F); after reconstitution, refrigerate at 2–8 Β°C (35.6–46.4 Β°F) and use within 30 days.

Notes

Practical considerations for consistency and tolerability. Use new sterile syringes for each injection; dispose in a sharps container. Rotate injection sites (abdomen, thighs, upper arms) weekly to reduce local irritation. Gradual dose escalation minimizes gastrointestinal side effects such as nausea [4] [6]. Document weekly dose, injection site, and any adverse effects to maintain consistency. For maintenance doses requiring >1.0 mL, ensure you have appropriately sized syringes (3 mL).

Single peptide protocol reference: Available for related research, development or formulation inquiry workflows.

Reconstitution and handling reference: Available for related research, development or formulation inquiry workflows.

Research-use documentation inquiry: Available for related research, development or formulation inquiry workflows.

Weeks 1–2
Weekly Dose (mg): 0.6 mg | Units (per injection): 18 units | Volume (mL): 0.18 mL
Weeks 3–4
Weekly Dose (mg): 1.2 mg | Units (per injection): 36 units | Volume (mL): 0.36 mL
Weeks 5–6
Weekly Dose (mg): 2.4 mg | Units (per injection): 72 units | Volume (mL): 0.72 mL
Weeks 7–16 (Maintenance)
Weekly Dose (mg): 4.5 mg | Units (per injection): 135 units | Volume (mL): 1.35 mL
Long-term Storage Conditions
Lyophilized: store frozen at βˆ’20 Β°C (βˆ’4 Β°F); after reconstitution, refrigerate at 2–8 Β°C (35.6–46.4 Β°F) and use within 30 days.
Shipping Condition
Shipping conditions by inquiry

Peptide Vials (Cagrilintide, 10 mg each): 8 weeks β‰ˆ 2 vials (17.4 mg total needed)

12 weeks β‰ˆ 4 vials (35.4 mg total needed)

16 weeks β‰ˆ 6 vials (53.4 mg total needed)

Syringes: Weeks 1–6 (doses ≀72 units): U‑100 insulin syringes work well

Weeks 7+ (doses >100 units): 3 mL syringes with 25–27G subcutaneous needles

Per week: 1 syringe

8 weeks: 8 syringes

12 weeks: 12 syringes

16 weeks: 16 syringes

Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution. 8 weeks (2 vials): 6 mL β†’ 1 Γ— 10 mL bottle

12 weeks (4 vials): 12 mL β†’ 2 Γ— 10 mL bottles

16 weeks (6 vials): 18 mL β†’ 2 Γ— 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each week. Per week: 2 swabs

8 weeks: 16 swabs

12 weeks: 24 swabs

16 weeks: 32 swabs β†’ recommend 1 Γ— 100‑count box

Product Gallery

Quick Inquiry

Customer Support & Price Inquiry

Send product, purity, quantity, destination and documentation requirements. Quantai will follow up through WhatsApp or email.

Email: kongq687@gmail.com

WhatsAppMia WhatsApp Business QR code

Address: Huangpu District, Guangzhou, China

Related Products

Related Services